Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624 ‐mediated PD‐L1 pathway

ConclusionApplying SAL might constrain malignant phenotypes and immune escape of LUAD cells partially through the circ_0009624-mediated PD-L1 pathway, providing a novel insight for LUAD treatment.

Source: Thoracic Cancer - July 9, 2023 Category: Cancer & Oncology Authors: Guilin Jin, Mi Ma, Chunyan Yang, Luo Zhen, Mingke Feng Tags: ORIGINAL ARTICLE Source Type: research